Key Market Segments
By Technology
-
Molecular Diagnostics
-
Immunoassays
-
Microbiological Culture
-
Point-of-Care Tests
-
Others
By Disease Type
-
Bacterial
-
Viral
-
Fungal
-
Parasitic
-
Others
By End-User
-
Hospitals
-
Diagnostic Laboratories
-
Clinics
-
Research Institutes
-
Others
By Distribution Channel
-
Direct Sales
-
Online Channels
-
Distributors
-
Others
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
North America dominated with a 36.87% share in 2025, while Asia-Pacific is the fastest-growing region, expected to expand at a CAGR of 9.87% during 2026–2035.
Molecular Diagnostics dominated with a 42.75% share in 2025, while Point-of-Care Tests are projected to grow at the fastest CAGR of 10.12% during 2026–2035.
Growth is driven by rising infections, demand for rapid diagnostics, and expanded healthcare infrastructure.
The market is valued at USD 28.42 Billion in 2025E and is projected to reach USD 63.26 Billion by 2035.
The Infectious Disease Diagnostics Market is expected to grow at a CAGR of 8.35% during 2026–2035.